Effects of Combined Oral Administration and Intravenous Injection on Maintaining Decreased Systemic Tyrosine Levels in Rats

References

• Abdi E. A., Hanson J., McPherson T. A. Adjuvant chemoimmunotherapy after regional lymphadenectomy for malignant melanoma. Am. J. Clin. Oncol. 1987; 10(2)117–122, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bezwoda W. R. The treatment of disseminated malignant melanoma with special reference to the role of interferons, vinca alkaloids and tamoxifen. Cancer Treat. Rev. 1997; 23(1)17–34, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bourget L., Chang T. M. S. Phenylalanine ammonia-lyase microencapsulated in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model. Biochim. Biophys. Acta 1986; 883: 423–438
   Google Scholar
• Bourget L., Chang T. M. S. Effects of oral administration of artificial cells microencapsulated phenylalanine ammonia-lyase on intestinal amino acids of phenylketonuric rats. Biomater. Artif. Cells Artif. Organs 1989; 17(2)161–181, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chang T. M. S. Monograph on Artificial Cells. Springfield, ILUSA 1972, Charles C. Thomas (free access at http://www.medicine. mcgill. ca/artcell/1972bookCover.pdf)
   Google Scholar
• Chang T. M. S. Artificial cells with regenerating multienzyme systems. Method. Enzymol. 1985; 112: 195–203
   PubMed Web of Science ®Google Scholar
• Chang T. M. S. Monograph on Blood Substitutes: Principles, Methods, Products and Clinical Trials. Karger Landes Systems, Basel, New York 1997, (free access at: http://www.medicine.mcgill.ca/ artcell/bloodsubvoll.pdf)
   Google Scholar
• Chang T. M. S., Bourget L., Lister C. A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in phenylketonuria. Artif. Cells Blood Substit. Immobil. Biotechnol. 1995; 25: 1–23, [CSA]
   Google Scholar
• Chang T. M. S., Prakash S. Procedure for microencapsulation of enzymes, cells and genetically engineered microorganisms. Mol. Biotechnol. 2001; 17: 249–260, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Charles M. H. Monograph on Cancer Treatment. W.B. Saunders, PhiladelphiaUSA 2001
   Google Scholar
• Cocconi G., Bella M., Calabresi F., Tonato M., Canaletti R., Boni C., Buzzi F., Ceci G., Corgna E., Costa P. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. New England J. Med. 1992; 327: 516–523
   PubMed Web of Science ®Google Scholar
• Cooper J. S. The evolution of the role of radiation therapy in the management of mucocutaneous malignant melanoma. Hematol. Oncol. Clin. North Am. 1998; 849–862, [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Demopoulos H. B. Effects of reducing the phenylalanine-tyrosine intake of patients with advanced malignant melanoma. Cancer 1966; 9: 657–664
   Google Scholar
• Fraker D. L. Hyperthermic regional perfusion for melanoma and sarcoma of the limbs. Curr. Probl. Surg. 1999; 36: 841–907, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fronticelli C., Bucci E. Conformation and functional characteristics of bovine hemoglobin. Method Enzymol. 1994; 231: 150–163
   PubMed Web of Science ®Google Scholar
• Fronticelli C., Bucci E., Orth C. Solvent regulation of oxygen affinity in hemoglobin. J. Biol. Chem. 1984; 259(17)10841–10844, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fronticelli C., Sanna M. T., Perez-Alvarado G. C., Karavitis M., Lu A. L., Brinigar W. S. Allosteric modulation by tertiary structure in mammalian hemoglobins Introduction of the functional characteristics of bovine hemoglobin into human hemoglobin by five amino acid substitutes. J. Biol. Chem. 1995; 270(51)30588–30592, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ge X., Fu Y. M., Li Y. Q., Meadows G. G. Activation of caspases and cleavage of Bid are required for tyrosine and phenylalanine deficiency-induced apoptosis of human A375 melanoma cells. Arch. Biochem. Biophys. 2002; 403: 50–58, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gennari R., Bartolomei M., Testori A., Zurrida S., Stoldt H. S., Audisio R. A., Geraghty J. G., Paganelli G., Veronesi U. Sentinel node localization in primary melanoma, preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance. Surgery 2000; 127: 19–25, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Halvorsen S., Gjessing L. R. Studies on tyrosinosis 1. Effect of low-tyrosine and low-phenylalanine diet. British. Med. J. 1964; 2: 1171–1173
   Google Scholar
• Lawson D. H., Stockton L. H., Bleier J. C., Acosta P. B., Heymsfield S. B., Nixon D. W. The effect of a phenylalanine and tyrosine restriction diet on elemental balance studies and plasma aminograms of patients with disseminated malignant melanoma. Am. J. Clin. Nutr. 1985; 41: 73–84, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Meadows G. G., Oeser D. E. Response of B16 melanoma-bearing mice to varying dietary levels of phenylalanine and tyrosine. Nutr. Rep. Int. 1983; 28: 1073–1082
   Google Scholar
• Meadows G. G., Pierson H. F., Abdallah R. M., Desai P. R. Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy. Cancer Res. 1982; 42: 3056–3063, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Meadows G. G., Zhang H., Ge X. Specific amino acid deficiency alters the expression of genes in human melanoma and other tumor cell lines. J. Nutr. 2001; 131: 3047S–3050S, [PUBMED], [INFOTRIEVE]
   Web of Science ®Google Scholar
• Meisenberg B. High-dose chemotherapy and autologous stem cell support for patients with malignant melanoma. Bone Marrow Transplant. 1996; 17: 903–906, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Pavey S., Gabrielli B. Alpha-melanocyte stimulating hormone potentiates p16/CDKN2A expression in human skin after ultraviolet irradiation. Cancer Res. 2002; 62: 875–880, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Pyrhonen S., Hahka-Kemppinen M., Muhonen T., Nikkanen V., Eskelin S., Summanen P., Tarkkanen A., Kivela T. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma. Cancer 2002; 95(11)2366–2372, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Quan W. D., Mitchell M. S. Immunology and immunotherapy of melanoma. Cancer Treat. Res. 1993; 65: 257–277, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Rosenberg S. A., Kawakami Y., Robbins P. F., Wang R. Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. Adv. Cancer Res. 1996; 70: 145–177, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A., Lotze M. T., Yang J. C., Topalian S. L., Chang A. E., Schwartzentruber D. J., Aebersold P., Leitman S., Linehan W. M., Seipp C. A. Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J. Natl. Cancer Inst. 1993; 85: 622–632, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Roses D. F., Provet J. A., Harris M. N., Gumport S. L., Dubin N. Prognosis of patients with pathologic stage II cutaneous malignant melanoma. Ann. Surg. 1985; 201: 103–107, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Serrone L., Zeuli M., Sega F. M., Cognetti F. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. J. Exp. Clin. Cancer Res. 2000; 19(1)21–34, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Veronesi U., Cascinelli N. Narrow excision (1-cm margin) A safe procedure for thin cutaneous melanoma. Arch. Surg. 1991; 126: 438–441, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Waalkes T. P., Udenferiend S. A fluorometric method for the estimation of tyrosine in plasma and tissues. J. Lab. Clin. Med. 1957; 11: 733–736
   Google Scholar
• Wolff S. N., Herzig R. H., Fay J. W., LeMaistre C. F., Frei-Lahr D., Lowder J., Bolwell B., Giannone L., Herzig G. P. High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation Group. J. Clin. Oncol. 1989; 7: 245–249, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wong J. H., Cagle L. A., Morton D. L. Surgical treatment of lymph nodes with metastatic melanoma from unknown primary site. Arch. Surg. 1987; 122: 1380–1383, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wong J. H., Steinemann S., Yonehara C., Coel M. N., Ko P. J., Tonaki K., Tauchi P. Sentinel node staging for cutaneous melanoma in a university-affiliated community care setting. Ann. Surg. Oncol. 2000; 7: 450–455, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yu B., Chang T. M. S. Artificial cells for the removal of systemic tyrosine in rats. Proc. Can. Fed. Biol. Soc. 45th Annu. Meet. (CFBS). 2002; 76
   Google Scholar
• Yu B., Chang T. M. S. In vitro enzyme kinetics of microencapsulated tyrosinase. Artif. Cells Blood Substit. Immobil. Biotechnol. 2002; 30: 533–546, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Yu B., Chang T. M. S. Effects of long term oral administration of microencapsulated tyrosinase on maintaining decreased systemic tyrosine levels in rats. Pharmaceutical Sciences 2004, (in press)[CSA]
   Web of Science ®Google Scholar
• Yu B., Chang T. M. S. In vitro and in vivo effects of polyhemoglobin-tyrosinase on murine B16F10 melanoma, (submitted)
   Google Scholar
• Yu W. P., Chang T. M. S. Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization. Artif. Cells Blood Substit. Immobil. Biotechnol. 1996; 24(3)169–183, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar